Smoking Cessation Lighter and Method
A lighter for tobacco products suppresses the urge to smoke by operant conditioning.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7439242 | PPARγ modulators Modulators of PPARγ activity are provided which are useful in pharmaceutical compositions and methods for the treatment of conditions such as type II diabetes and obesity. ... | 10/21/2008 |
| 7378530 | Anti-cancer and anti-microbial 5-membered heterocyclic compounds Disclosed herein are various novel oxazolidinone, imidazolidinone, and thiazolidinone analogs and methods of treating cancer and/or microbial infection using these analogs. Particular 4-oxazolidinone compounds are shown to have anti-cancer and anti-microbial activit... | 05/27/2008 |
| 7309791 | 3-phenylpropionic acid derivatives The invention relates to new compounds, being 3-phenylpropionic acid derivatives of formula I wherein W represents COOH group or its bioisosters, or —COO—C1–C4-alkyl group; Y represents NH, N—C1–C10-alkyl, O, or ... | 12/18/2007 |
| 7279582 | Retroviral protease inhibiting compounds A compound of the formula: is disclosed as an HIV protease inhibitor. Methods and compositions for inhibiting an HIV infection are also disclosed. ... | 10/09/2007 |
| 7109202 | Aminothaizoles and their use as adenosine receptor antagonists Compounds of formula (I) in free or salt form, where A is a C6-C15 monovalent aromatic group. R1 is hydrogen, phenyl optionally substituted by one or more substituents selected from halogen, cyano, hydroxy, C1–C8 | 09/19/2006 |
| 7087763 | Process for preparation of alkylimidazolidone (meth)acrylates The invention relates to a process for the preparation of alkylimidazolidone (meth)acrylates, generally expressed as compound (I): that are prepared by reacting at least one (meth)acrylate of formula (II): | 08/08/2006 |
| 7074937 | Method for production of additives for lubricating oils A method for making a compound of formula (I) wherein bonds a and b are single or double bonds, provided that one of a and b is a single bond and the other is a double bond; one of B1 and B2 | 07/11/2006 |
| 7071223 | Benzamide inhibitors of the P2Xreceptor The present invention provides benzamide inhibitors of the P2X7 receptor of the formula: wherein R1–R3 are as defined herein. The compounds of the invention are useful in the trea... | 07/04/2006 |
| 6930076 | Nematicidal trifluorobutenyl imidazole thioether derivatives The present invention relates to novel trifluorobutenyl imidazole thioether derivatives of the following formula (I) wherein R1 represents hydrogen or halogen, ... | 08/16/2005 |
| 6916837 | Amidino derivatives and anticoagulants and thrombosis therapeutic agents containing them Amidino derivatives represented by the following general formula (I): {where X is a group represented by R1SO2NR2— (wherein R1 represents optionally substituted C6-14 ... | 07/12/2005 |
| 6815445 | Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes The present invention is directed to a compound of Formula I: wherein A, R1, and R2 are defined herein. The present invention is also directed to compositions comprising compounds of Formula I, me... | 11/09/2004 |
| 6706887 | Process for the preparation of alkylimidazolidone (meth)acrylates The invention relates to a process for the preparation of alkylimidazolidone (meth)acrylates, generally expressed as compound (I): that are prepared by reacting at least one (meth)acrylate of formula (II): | 03/16/2004 |
| 6696456 | Beta disubstituted metalloprotease inhibitors Disclosed are compounds which are inhibitors of metalloproteases and which are effective in treating conditions characterized by excess activity of these enzymes. In particular, the compounds have a structure according to the following Formula (I): #... | 02/24/2004 |
| 6586452 | C1 to C4 side chain modified nodulisporic acid analogs The present invention relates to novel nodulosporic acid derivatives, which are acaricidal, antiparasitic, insecticidal and anthelmintic agents.... | 07/01/2003 |
| 6545157 | Dye-forming method, color developing compositions, photosensitive materials and color developing agent precursors A dye-forming method comprising: reacting a dye-forming coupler and a color developing agent precursor represented by the following general formula (I): ##STR1## wherein A3 represents a group other than a hydrogen atom which leaves, accomp... | 04/08/2003 |
| 6541635 | Method for producing angiotensin converting enzyme inhibitor The present invention discloses a method for producing angiotensin converting enzyme inhibitor of the following formula (I) and pharmaceutically acceptable salts thereof, in which a compound of the following formula (II), ##STR1## wherein R and R | 04/01/2003 |
| 6515138 | Transesterification process An improved transesterification process is disclosed for forming certain (meth)acrylates by the transesterification of an alkyl (meth)acrylate with a hydroxyl alkyl imidazolidin-2-one using a transesterification catalyst in the presence of a polymerizatio... | 02/04/2003 |
| 6479478 | Carbapenem compounds It is provided carbapenem compounds represented by the following formula (I): ##STR1## wherein R is hydrogen atom, or substituted or unsubstituted lower alkyl group; and, n is an integer of 1 or 2, or a pharmaceutically acceptable salt thereof, and an antibact... | 11/12/2002 |
| 6472529 | Retroviral protease inhibiting compounds A compound of the formula: ##STR1## is disclosed as an HIV protease inhibitor. Methods and compositions for inhibiting an HIV infection are also disclosed.... | 10/29/2002 |
| 6472414 | Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method Novel compounds are provided which are inhibitors of MTP and thus are useful for lowering serum lipids and treating atherosclerosis and related diseases, and have the structure ##STR1## including pharmaceutically acceptable salts thereof or prodrug esters... | 10/29/2002 |
| 6465650 | Substituted N-ethylglycine derivatives for preparing PNA and PNA/DNA hybrids The invention provides a processes for the preparation of a compound of Formula I, or a salt thereof ##STR1## wherein PG is a urethane- or trityl-type protective group; X is NH, O, or S; Y is CH2, O, or NH; and B' is a base customary in nucleot... | 10/15/2002 |
| 6362183 | Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds An aromatic sulfonyl alpha-hydroxy hydroxamic acid compound that, inter alia, inhibits matrix metalloprotease activity is disclosed, as is a treatment process that comprises administering a contemplated aromatic sulfonyl alpha-hydroxy hydroxamic acid comp... | 03/26/2002 |
| 6335451 | Five-membered heterocycles having biphenylsulfonyl substitution, with sulfonylcyanamide side chain, compositions containing them, and methods of using them Five-membered heterocycles having biphenylsulfonyl substitution, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them. Compounds of the formula I ##STR1## in which the symbols have the meanings indicated i... | 01/01/2002 |
| 6228848 | Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities Aryl-substituted and aryl and (3-oxo-1-propenly)-substituted benzopyran, benzothiopyran, 1,2-dihydroquinoline, and 5,6-dihydronaphthalene derivatives have retinoid negative hormone and/or antagonist-like biological activities. The invented RAR antagonists... | 05/08/2001 |
| 6191157 | Hetero-linked phenylglycinolamides The hetero-linked phenylglycinolamides are prepared by reaction of the corresponding hetero-linked phenylacetic acids with appropriate phenylglycinols. The hetero-linked phenylglycinolamides are suitable as active compounds in medicaments.... | 02/20/2001 |
| 6179906 | Cyclic urea surfactants This invention provides water-based compositions, particularly coating, ink, and agricultural compositions, manifesting reduced equilibrium and dynamic surface tension by the incorporation of a surface tension reducing amount of certain cyclic urea compou... | 01/30/2001 |
| 6172057 | N-Hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors Matrix metalloproteinases (MMPs) are a group of enzymes that have been implicated in the pathological destruction of connective tissue and basement membranes. These zinc containing endopeptidases consist of several subsets of enzymes including collagenase... | 01/09/2001 |
| 6166220 | Ethylenically unsaturated imidazidolidinone monomers Classes of urea functional compounds and compositions containing the same are disclosed which are particularly suitable for use as a wet adhesion promoters in coatings, especially in aqueous emulsion systems used to make latex paints. Compositions contain... | 12/26/2000 |
| 6147097 | Imidazole derivatives as anti-HIV agents An imidazole derivative represented by general formula (I) or a salt thereof, having the effect of specifically inhibiting the growth of HIV as a pathogenic virus and being reduced in toxicity. In said formula R1 represents hydrogen, C1 | 11/14/2000 |
| 6080870 | Biaryl substituted imidazole compounds useful as farnesyl-protein transferase inhibitors The present invention is directed to compounds which inhibit farnesyl-protein transferase (FTase) and the farnesylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invent... | 06/27/2000 |
| 6075143 | Substituted N-ethylglycine derivatives for preparing PNA and PNA/DNA hybrids There are described N-ethylglycine derivatives of the formula I ##STR1## in which PG is a urethane-type or trityl-type amino protective group which is labile to weak acids, X is NH, O or S, Y is CH2, NH or O, and B' are bases customary in ... | 06/13/2000 |
| 6071935 | Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one and their use as farnesyl protein transferase inhibitors The present invention relates to compounds of the formula ##STR1## wherein R1, R2, R3 and R4 are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of form... | 06/06/2000 |
| 6057448 | Process for producing imidazole derivatives The present invention provides a process for producing a compound of the formula (III): ##STR1## wherein R1 and R3 are independently hydrogen or an organic group; R2 is an organic group; and R4 is an option... | 05/02/2000 |
| 6056965 | 2-mercapto-imidazole derivatives substituted in position 4 (or 5) as antioxidizing agents, method of preparation and applications in the pharmaceutical, cosmetic or food industries The invention relates to 2-mercaptoimidazole derivatives substituted in the 4(or 5)-position. These 2-mercaptoimidazole derivatives are of the general formula (I) below: ##STR1## wherein: R1, R2, R5, R7 and R | 05/02/2000 |
| 6054590 | Imidazolone anorectic agents: II. phenyl derivatives A series of non-peptidergic antagonists of NPY have been synthesized and are comprised of phenyl derivatives of imidazolone compounds of Formula I. ##STR1## As antagonists of NPY-induced feeding behavior, these compounds and known analogs are expecte... | 04/25/2000 |
| 6040328 | Aromatic diselenides and selenosulfides, their preparation and their uses, more particularly their therapeutical use The objects of the present invention are: novel organoselenium compounds: aromatic diselenides and selenosulphides; the use of said novel compounds as antioxidant agents; pharmaceutical compositions containing them; a method of preparation of said novel compounds. Said ... | 03/21/2000 |
| 6018049 | Process for the preparation of carbamoylated imidazole derivatives The present invention provides a process for the preparation of a compound of the formula (III): ##STR1## wherein R1 is an optionally substituted alkyl or an optionally substituted aryl; R2 is an optionally substituted alkyl: R | 01/25/2000 |
| 6008371 | Process for the preparation of (meth)acrylic acid esters A catalytic process for the preparation of (meth)acrylic acid esters of formula (I), in which R1 is H or CH3 and A and B are unbranched or branched alkylene groups with 2 to 5 C-atoms, by reaction of (meth)acrylic acid esters of formula (II), i... | 12/28/1999 |
| 5977377 | Process for producing N-alkylimidazole Disclosed is a process for producing an N-alkylimidazole which comprises reacting an imidazole with an N-alkylating agent in an organic solvent in the presence of alkali particles having a specific surface area of 0.6 M2 /g or larger.... | 11/02/1999 |
| 5952510 | 1,3-dihydro-1-(phenylalkenyl)-2H-imidazol-2-one derivatives having PDE IV and cytokine inhibiting activity The present invention concerns the compounds of formula ##STR1## the N-oxide forms, the pharmaceutically acceptable acid or base addition salts and the stereochemically isomeric forms thereof, wherein R1 and R2 each independentl... | 09/14/1999 |